TapewireFind a company

person · Reporting owner

Waters Michael Willem

Disclosed activity across 1 company

Tapewire entity
87797
SEC CIK
0001936444

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Teladoc Health, Inc.TDOC · Entity 1547CHIEF OPERATING OFFICERAugust 30, 2024September 04, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Teladoc Health, Inc.

Report date August 30, 2024 · Filed September 04, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect78,309 Ending reported balance After 2024-09-03 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2024-08-30 · Exercise / conversion · Acquired 2,113 · Balance 76,327

F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Row 2 · 2024-08-30 · Exercise / conversion · Acquired 6,200 · Balance 82,527

F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Row 3 · 2024-09-03 · Sale · Disposed 4,218 · Balance 78,309

F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Performance Stock UnitsSEC Table II · derivative / convertible securityDirect12,679 Reported balance After 2024-08-30 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2024-08-30 · Exercise / conversion · Disposed 2,113 · Balance 12,679

F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect37,204 Reported balance After 2024-08-30 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2024-08-30 · Exercise / conversion · Disposed 6,200 · Balance 37,204

F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5: On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F2: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

F4: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F5: On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 03, 2024 Filed Sep 4, 2024 20:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 4,218 $7.16 $30,217.75
Disclosure

SEC source: 0001477449-24-000187 · wk-form4_1725480704.xml · nonDerivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,309

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 20:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 6,200 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000187 · wk-form4_1725480704.xml · derivative · entry 5

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,204

Underlying: Common Stock · 6,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 20:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 2,113 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000187 · wk-form4_1725480704.xml · derivative · entry 4

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,679

Underlying: Common Stock · 2,113 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 20:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 6,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000187 · wk-form4_1725480704.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,527

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 20:11 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 2,113 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000187 · wk-form4_1725480704.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,327

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
August 02, 2024 Filed Aug 5, 2024 21:01 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 6,053 $8.14 $49,283.53
Disclosure

SEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,214

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 21:01 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 11,319 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · derivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,280

Underlying: Common Stock · 11,319 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 21:01 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 11,319 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 4,246 $11.16 $47,372.62
Disclosure

SEC source: 0001477449-24-000152 · wk-form4_1717531594.xml · nonDerivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,948

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 6,200 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000152 · wk-form4_1717531594.xml · derivative · entry 5

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,404

Underlying: Common Stock · 6,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 2,113 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000152 · wk-form4_1717531594.xml · derivative · entry 4

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,792

Underlying: Common Stock · 2,113 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 25,357 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 25,357 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 6,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000152 · wk-form4_1717531594.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:06 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 2,113 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000152 · wk-form4_1717531594.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,994

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 02, 2024 Filed May 2, 2024 20:05 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 5,793 $12.69 $73,501.58
Disclosure

SEC source: 0001477449-24-000106 · wk-form4_1714680325.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,881

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
May 01, 2024 Filed May 2, 2024 20:05 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 11,319 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000106 · wk-form4_1714680325.xml · derivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,599

Underlying: Common Stock · 11,319 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 01, 2024 Filed May 2, 2024 20:05 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 11,319 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000106 · wk-form4_1714680325.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 19, 2024 Filed Mar 20, 2024 20:09 UTC Teladoc Health, Inc. TDOC · Entity 1547 GrantRestricted Stock Units · Derivative 87,500 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000067 · wk-form4_1710965390.xml · derivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,500

Underlying: Common Stock · 87,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 21:10 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 12,468 $14.52 $180,985.49
Disclosure

SEC source: 0001477449-24-000047 · wk-form4_1709673019.xml · nonDerivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,355

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:10 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 24,801 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000047 · wk-form4_1709673019.xml · derivative · entry 6

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,604

Underlying: Common Stock · 24,801 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F8 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F8 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:10 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionPerformance Stock Units · Derivative 8,452 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000047 · wk-form4_1709673019.xml · derivative · entry 5

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,905

Underlying: Common Stock · 8,452 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F7 · derivative.exercise_date: On March 1, 2024, the reporting person earned 25,357 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F7 · derivative.expiration_date: On March 1, 2024, the reporting person earned 25,357 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:10 UTC Teladoc Health, Inc. TDOC · Entity 1547 GrantPerformance Stock Units · Derivative 25,357 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000047 · wk-form4_1709673019.xml · derivative · entry 4

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,357

Underlying: Common Stock · 25,357 shares

Expires not disclosed

F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock.

F5 · shares: Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.

F6 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F6 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:10 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 24,801 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000047 · wk-form4_1709673019.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:10 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 8,452 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000047 · wk-form4_1709673019.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,022

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
February 02, 2024 Filed Feb 2, 2024 22:04 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 4,523 $19.18 $86,742.09
Disclosure

SEC source: 0001477449-24-000012 · wk-form4_1706911461.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,570

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 22:04 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 11,319 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000012 · wk-form4_1706911461.xml · derivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,918

Underlying: Common Stock · 11,319 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 22:04 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 11,319 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000012 · wk-form4_1706911461.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
November 02, 2023 Filed Nov 3, 2023 21:15 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 5,482 $17.05 $93,446.17
Disclosure

SEC source: 0001477449-23-000073 · wk-form4_1699046128.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,774

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:15 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 11,319 $0.00 $0.00
Disclosure

SEC source: 0001477449-23-000073 · wk-form4_1699046128.xml · derivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,237

Underlying: Common Stock · 11,319 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:15 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 11,319 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-23-000073 · wk-form4_1699046128.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,256

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
August 02, 2023 Filed Aug 3, 2023 20:15 UTC Teladoc Health, Inc. TDOC · Entity 1547 SaleCommon Stock 19,340 $27.03 $522,740.86
Disclosure

SEC source: 0001477449-23-000022 · wk-form4_1691093745.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,937

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 20:15 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionRestricted Stock Units · Derivative 45,277 $0.00 $0.00
Disclosure

SEC source: 0001477449-23-000022 · wk-form4_1691093745.xml · derivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,556

Underlying: Common Stock · 45,277 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 20:15 UTC Teladoc Health, Inc. TDOC · Entity 1547 Exercise / conversionCommon Stock 45,277 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-23-000022 · wk-form4_1691093745.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,277

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:10 UTC Teladoc Health, Inc. TDOC · Entity 1547 GrantRestricted Stock Units · Derivative 74,405 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-004408 · form4-03072023_090307.xml · derivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,405

Underlying: Common Stock · 74,405 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 20:20 UTC Teladoc Health, Inc. TDOC · Entity 1547 GrantRestricted Stock Units · Derivative 135,833 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-008111 · form4-08022022_010837.xml · derivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,833

Underlying: Common Stock · 135,833 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: One-third of the restricted stock units vest on August 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F2 · derivative.expiration_date: One-third of the restricted stock units vest on August 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.